医学
肿瘤科
乳腺癌
荟萃分析
内科学
新辅助治疗
曲妥珠单抗
癌症
作者
Ruiliang Chen,Yushuai Yu,Jie Zhang,Chuangui Song,Chuan Wang
标识
DOI:10.1080/14737140.2024.2350105
摘要
Neoadjuvant treatment for hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer is controversial and requires a comprehensive analysis for optimal therapy assessment. Therefore, a two-step Bayesian network meta-analysis (NMA) was performed to compare the efficacy and safety of different neoadjuvant regimens.
科研通智能强力驱动
Strongly Powered by AbleSci AI